Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait.
HbE β-thalassemia is the most common severe thalassemia syndrome across Asia, and millions are carriers. Clinical heterogeneity in HbE β-thalassemia is incompletely explained by genotype, and the interaction of phenotypic variation with hepcidin is unknown. The effect of thalassemia carriage on hepc...
| Príomhchruthaitheoirí: | , , , , , , , , , , , , , , , , |
|---|---|
| Formáid: | Journal article |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
2014
|
| _version_ | 1826289728314408960 |
|---|---|
| author | Jones, E Pasricha, SR Allen, A Evans, P Fisher, C Wray, K Premawardhena, A Bandara, D Perera, A Webster, C Sturges, P Olivieri, N St Pierre, T Armitage, A Porter, J Weatherall, D Drakesmith, H |
| author_facet | Jones, E Pasricha, SR Allen, A Evans, P Fisher, C Wray, K Premawardhena, A Bandara, D Perera, A Webster, C Sturges, P Olivieri, N St Pierre, T Armitage, A Porter, J Weatherall, D Drakesmith, H |
| author_sort | Jones, E |
| collection | OXFORD |
| description | HbE β-thalassemia is the most common severe thalassemia syndrome across Asia, and millions are carriers. Clinical heterogeneity in HbE β-thalassemia is incompletely explained by genotype, and the interaction of phenotypic variation with hepcidin is unknown. The effect of thalassemia carriage on hepcidin is also unknown, but could be relevant for iron supplementation programs aimed at combating anemia. In 69 Sri Lankan HbE β-thalassemia patients with moderate or severe phenotype, hepcidin was suppressed in 62/69 patients, and overall hepcidin inversely correlated with iron accumulation. On segregating by phenotype, there were no differences in hepcidin, erythropoiesis or hemoglobin between severe or moderate disease, but multiple linear regression showed that erythropoiesis inversely correlated with hepcidin only in severe phenotypes. In moderate disease, no independent predictors of hepcidin were identifiable; nevertheless the low hepcidin levels indicate a significant risk of iron overload. In a population survey of Sri Lankan schoolchildren, β-thalassemia (but not HbE) trait associated with increased erythropoiesis and mildly suppressed hepcidin, suggesting an enhanced propensity to accumulate iron. In summary, the influence of erythropoiesis on hepcidin suppression associates with phenotypic disease variation and pathogenesis in HbE β-thalassemia, and indicates the epidemiology of β-thalassemia trait requires consideration when planning public health iron interventions. |
| first_indexed | 2024-03-07T02:33:19Z |
| format | Journal article |
| id | oxford-uuid:a7f692e7-c190-4eeb-bf91-d6b6af39adf1 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T02:33:19Z |
| publishDate | 2014 |
| record_format | dspace |
| spelling | oxford-uuid:a7f692e7-c190-4eeb-bf91-d6b6af39adf12022-03-27T02:58:09ZHepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a7f692e7-c190-4eeb-bf91-d6b6af39adf1EnglishSymplectic Elements at Oxford2014Jones, EPasricha, SRAllen, AEvans, PFisher, CWray, KPremawardhena, ABandara, DPerera, AWebster, CSturges, POlivieri, NSt Pierre, TArmitage, APorter, JWeatherall, DDrakesmith, HHbE β-thalassemia is the most common severe thalassemia syndrome across Asia, and millions are carriers. Clinical heterogeneity in HbE β-thalassemia is incompletely explained by genotype, and the interaction of phenotypic variation with hepcidin is unknown. The effect of thalassemia carriage on hepcidin is also unknown, but could be relevant for iron supplementation programs aimed at combating anemia. In 69 Sri Lankan HbE β-thalassemia patients with moderate or severe phenotype, hepcidin was suppressed in 62/69 patients, and overall hepcidin inversely correlated with iron accumulation. On segregating by phenotype, there were no differences in hepcidin, erythropoiesis or hemoglobin between severe or moderate disease, but multiple linear regression showed that erythropoiesis inversely correlated with hepcidin only in severe phenotypes. In moderate disease, no independent predictors of hepcidin were identifiable; nevertheless the low hepcidin levels indicate a significant risk of iron overload. In a population survey of Sri Lankan schoolchildren, β-thalassemia (but not HbE) trait associated with increased erythropoiesis and mildly suppressed hepcidin, suggesting an enhanced propensity to accumulate iron. In summary, the influence of erythropoiesis on hepcidin suppression associates with phenotypic disease variation and pathogenesis in HbE β-thalassemia, and indicates the epidemiology of β-thalassemia trait requires consideration when planning public health iron interventions. |
| spellingShingle | Jones, E Pasricha, SR Allen, A Evans, P Fisher, C Wray, K Premawardhena, A Bandara, D Perera, A Webster, C Sturges, P Olivieri, N St Pierre, T Armitage, A Porter, J Weatherall, D Drakesmith, H Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait. |
| title | Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait. |
| title_full | Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait. |
| title_fullStr | Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait. |
| title_full_unstemmed | Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait. |
| title_short | Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait. |
| title_sort | hepcidin is suppressed by erythropoiesis in hemoglobin e β thalassemia and β thalassemia trait |
| work_keys_str_mv | AT jonese hepcidinissuppressedbyerythropoiesisinhemoglobinebthalassemiaandbthalassemiatrait AT pasrichasr hepcidinissuppressedbyerythropoiesisinhemoglobinebthalassemiaandbthalassemiatrait AT allena hepcidinissuppressedbyerythropoiesisinhemoglobinebthalassemiaandbthalassemiatrait AT evansp hepcidinissuppressedbyerythropoiesisinhemoglobinebthalassemiaandbthalassemiatrait AT fisherc hepcidinissuppressedbyerythropoiesisinhemoglobinebthalassemiaandbthalassemiatrait AT wrayk hepcidinissuppressedbyerythropoiesisinhemoglobinebthalassemiaandbthalassemiatrait AT premawardhenaa hepcidinissuppressedbyerythropoiesisinhemoglobinebthalassemiaandbthalassemiatrait AT bandarad hepcidinissuppressedbyerythropoiesisinhemoglobinebthalassemiaandbthalassemiatrait AT pereraa hepcidinissuppressedbyerythropoiesisinhemoglobinebthalassemiaandbthalassemiatrait AT websterc hepcidinissuppressedbyerythropoiesisinhemoglobinebthalassemiaandbthalassemiatrait AT sturgesp hepcidinissuppressedbyerythropoiesisinhemoglobinebthalassemiaandbthalassemiatrait AT olivierin hepcidinissuppressedbyerythropoiesisinhemoglobinebthalassemiaandbthalassemiatrait AT stpierret hepcidinissuppressedbyerythropoiesisinhemoglobinebthalassemiaandbthalassemiatrait AT armitagea hepcidinissuppressedbyerythropoiesisinhemoglobinebthalassemiaandbthalassemiatrait AT porterj hepcidinissuppressedbyerythropoiesisinhemoglobinebthalassemiaandbthalassemiatrait AT weatheralld hepcidinissuppressedbyerythropoiesisinhemoglobinebthalassemiaandbthalassemiatrait AT drakesmithh hepcidinissuppressedbyerythropoiesisinhemoglobinebthalassemiaandbthalassemiatrait |